BridgeMD
A Study of Baricitinib (LY3009104) in Children With COVID-19 (COV-BARRIER)
EU CTIS ID: 2024-516824-32-00
What this study is testing
To characterize the pharmacokinetics (PK) of baricitinib in pediatric patients with COVID-19
- Therapeutic confirmatory (Phase III)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Participants must be hospitalized with coronavirus (COVID-19) infection
- Participants must need oxygen therapy
You likely can't join if
- Participants must not be taking biologic therapy or other drugs which suppresses the body’s immune response
- Participants must not have active tuberculosis (TB)
- Participants must not have any other serious infection (besides COVID-19)
- Participants must not need a machine to help them breathe (ventilator) at study entry
- Participants must not have Cancer
- Participants must not have a history of a blood clot
See the full eligibility criteria
- Participants must be hospitalized with coronavirus (COVID-19) infection
- Participants must need oxygen therapy
- Participants must not be taking biologic therapy or other drugs which suppresses the body’s immune response
- Participants must not have active tuberculosis (TB)
- Participants must not have any other serious infection (besides COVID-19)
- Participants must not need a machine to help them breathe (ventilator) at study entry
- Participants must not have Cancer
- Participants must not have a history of a blood clot
- Participants must not be pregnant or breastfeeding
The study team makes the final eligibility decision.
Where it's taking place
- Mexico
- Brazil
- United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0-17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Mexico; Brazil; United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.